Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02571907 · ClinicalTrials.gov registry record · NA
PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation Clinical Study
A NA study, sponsored by Cook Research Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT02571907 is a NA study that has completed, run by Cook Research Incorporated. The registered enrollment target is 40 participants.
The verdict
NCT02571907, a NA study, has completed, sponsored by Cook Research Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this extended study is to evaluate the safety and effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation in combination with the commercially available Atrium iCAST™ covered stent in patients in a treatment of aortoiliac and iliac aneurysms.
Interventions
- DEVICE Zenith® Branch Endovascular Graft-Iliac Bifurcation,
- DEVICE Atrium iCAST™
- DEVICE Zenith® Flex AAA Endovascular Graft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2014-04-01 |
| Est. Completion | 2020-11-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02571907
The ClinicalTrials.gov registry entry for NCT02571907 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cook Research Incorporated, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Zenith® Branch Endovascular Graft-Iliac Bifurcation, is the first listed.
NCT02571907 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02571907 about?
NCT02571907 is a clinical study titled "PRESERVE-Zenith® Branch Endovascular Graft-Iliac Bifurcation Clinical Study". The purpose of this extended study is to evaluate the safety and effectiveness of the Zenith® Branch Endovascular Graft-Iliac Bifurcation in combination with the commercially available Atrium iCAST™ covered stent in patients in a treatment of aortoiliac and iliac aneurysms.
What is the current status of trial NCT02571907?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2014-04-01. Estimated completion is 2020-11-04.
What interventions are being tested in trial NCT02571907?
The interventions under investigation include: Zenith® Branch Endovascular Graft-Iliac Bifurcation, (DEVICE), Atrium iCAST™ (DEVICE), Zenith® Flex AAA Endovascular Graft (DEVICE).
Who is sponsoring clinical trial NCT02571907?
This trial is sponsored by Cook Research Incorporated, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.